Corporate Profile

Simulations Plus, Inc. (NASDAQ GSM: SLP) is the leading developer of modeling and simulation software for the pharmaceutical and biotechnology industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better project decisions… sooner.

Latest Quarterly Results

4th Quarter and Fiscal Year 2021 Results Press Release

4th Quarter and Fiscal Year 2021 Earnings Release Presentation

4th Quarter and Fiscal Year 2021 Webcast Info

4th Quarter and Fiscal Year 2021 Transcript

Upcoming Investor Presentation

There are no upcoming presentations currently scheduled